Surgical Metastasectomy in the Spine: A Review Article.


Journal

The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837

Informations de publication

Date de publication:
10 2021
Historique:
received: 24 08 2020
accepted: 20 05 2021
pubmed: 3 6 2021
medline: 26 10 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

The use of surgical metastasectomy (SM) has increased across cancer types in recent decades despite the increasing efficacy of modern systemic treatment modalities. Symptomatic spinal metastases severely compromise patients' performance status. However, as spinal SM is a complex surgery with potentially significant complications, it is not considered the treatment of choice. We reviewed the articles on SM in several primary cancers with different types of metastatic lesions and extracted the data from relevant articles to provide a comprehensive review including the surgical techniques, indications, reported outcomes, and future prospects of SM in spinal metastases. Total en bloc spondylectomy (TES) is a method of spinal SM associated with a lower risk of tumor recurrence and complications. Intralesional transpedicular osteotomy using a fine threadwire saw allows prevention of spinal cord and nerve root injuries. Spinal SM is considered suitable for patients with controlled primary disease having no evidence of disseminated extraspinal metastases, a completely resectable solitary lesion in the spine, and adequate cardiopulmonary reserve to tolerate the surgery. Metastatic lesions from kidney and thyroid cancers have been reported as the best candidates for spinal SM. Although data about spinal SM are limited, the reported outcomes are favorable with acceptable local recurrence rates in long-term follow-up. In patients with isolated resectable spinal metastases, complete SM including TES is a useful option as it can improve function and survival. However, appropriate patient selection and surgical feasibility remain the most important aspects of management. Surgical metastasectomy for spinal metastases may be a potentially curative treatment option with a low risk of local recurrence and lead to prolonged long-term survival if appropriate patients are selected and if the surgery is carried out by experienced surgeons in high-volume centers.

Sections du résumé

BACKGROUND
The use of surgical metastasectomy (SM) has increased across cancer types in recent decades despite the increasing efficacy of modern systemic treatment modalities. Symptomatic spinal metastases severely compromise patients' performance status. However, as spinal SM is a complex surgery with potentially significant complications, it is not considered the treatment of choice.
METHODS
We reviewed the articles on SM in several primary cancers with different types of metastatic lesions and extracted the data from relevant articles to provide a comprehensive review including the surgical techniques, indications, reported outcomes, and future prospects of SM in spinal metastases.
RESULTS
Total en bloc spondylectomy (TES) is a method of spinal SM associated with a lower risk of tumor recurrence and complications. Intralesional transpedicular osteotomy using a fine threadwire saw allows prevention of spinal cord and nerve root injuries. Spinal SM is considered suitable for patients with controlled primary disease having no evidence of disseminated extraspinal metastases, a completely resectable solitary lesion in the spine, and adequate cardiopulmonary reserve to tolerate the surgery. Metastatic lesions from kidney and thyroid cancers have been reported as the best candidates for spinal SM. Although data about spinal SM are limited, the reported outcomes are favorable with acceptable local recurrence rates in long-term follow-up.
CONCLUSION
In patients with isolated resectable spinal metastases, complete SM including TES is a useful option as it can improve function and survival. However, appropriate patient selection and surgical feasibility remain the most important aspects of management.
IMPLICATIONS FOR PRACTICE
Surgical metastasectomy for spinal metastases may be a potentially curative treatment option with a low risk of local recurrence and lead to prolonged long-term survival if appropriate patients are selected and if the surgery is carried out by experienced surgeons in high-volume centers.

Identifiants

pubmed: 34076920
doi: 10.1002/onco.13840
pmc: PMC8488775
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1833-e1843

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 AlphaMed Press.

Références

Ann Thorac Cardiovasc Surg. 2019 Dec 20;25(6):289-295
pubmed: 31723083
Neurosurgery. 1991 Nov;29(5):645-50
pubmed: 1961391
Eur Spine J. 2018 Apr;27(4):859-867
pubmed: 28653097
Eur J Cancer. 2019 Jan;107:79-85
pubmed: 30551078
Clin Transl Oncol. 2019 Jan;21(1):3-17
pubmed: 30446985
J Neurosurg Spine. 2015 Jan;22(1):52-9
pubmed: 25360530
Cancer. 2015 Mar 1;121(5):747-57
pubmed: 25377689
J Thorac Cardiovasc Surg. 2015 Jan;149(1):85-92
pubmed: 25312228
J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49
pubmed: 9011700
Eur Spine J. 2013 Mar;22(3):556-64
pubmed: 22864795
Cancer. 2008 Jan 1;112(1):157-61
pubmed: 17948910
J Neurosurg Spine. 2016 Jan;24(1):131-44
pubmed: 26360144
Spine (Phila Pa 1976). 1990 Nov;15(11):1110-3
pubmed: 1702559
Am J Clin Oncol. 2018 Jul;41(7):681-686
pubmed: 27819879
Asia Pac J Clin Oncol. 2012 Sep;8(3):292-302
pubmed: 22897801
Cancer Med. 2014 Oct;3(5):1359-67
pubmed: 25044999
Asian Spine J. 2019 Apr;13(2):296-304
pubmed: 30481978
Eur J Cardiothorac Surg. 2014 Apr;45(4):671-6
pubmed: 24092503
J Orthop Sci. 2006 Jan;11(1):3-12
pubmed: 16437342
Surgery. 1976 Jun;79(6):669-73
pubmed: 179160
Bone Joint J. 2021 May;103-B(5):976-983
pubmed: 33934644
World Neurosurg. 2019 Mar;123:e371-e378
pubmed: 30500586
J Bone Joint Surg Br. 2002 May;84(4):521-9
pubmed: 12043772
Cancer. 2011 Oct 15;117(20):4740-06
pubmed: 21455999
J Neurosurg Spine. 2011 Feb;14(2):172-6
pubmed: 21184643
J Clin Oncol. 2011 Mar 10;29(8):1083-90
pubmed: 21263087
J Neurooncol. 2014 Aug;119(1):121-8
pubmed: 24792488
Eur Urol Oncol. 2019 Mar;2(2):141-149
pubmed: 31017089
J Spinal Disord Tech. 2012 Apr;25(2):E7-12
pubmed: 22105102
Ann Surg Oncol. 2017 Dec;24(13):3991-4000
pubmed: 29019177
World J Clin Oncol. 2019 Oct 24;10(10):318-339
pubmed: 31799148
Arch Surg. 2004 Sep;139(9):961-6; discussion 966-7
pubmed: 15381613
Ann Surg Oncol. 2013 Feb;20(2):572-9
pubmed: 23104709
Arch Surg. 1997 Apr;132(4):338-46
pubmed: 9108752
J Clin Endocrinol Metab. 2012 Jul;97(7):2433-9
pubmed: 22564664
Eur Spine J. 2020 Feb;29(2):248-256
pubmed: 31641907
Oncologist. 2004;9(2):188-96
pubmed: 15047923
J Surg Oncol. 2015 Jun;111(8):980-4
pubmed: 26080731
N Engl J Med. 2011 Jun 2;364(22):2128-37
pubmed: 21631325
J Bone Joint Surg Br. 1971 May;53(2):288-95
pubmed: 4931082
J Neurosurg Spine. 2012 Oct;17(4):271-9
pubmed: 22881038
Adv Radiat Oncol. 2018 Apr 10;3(3):245-251
pubmed: 30202794
Cancer Med. 2016 Sep;5(9):2343-9
pubmed: 27431619
Am Surg. 2020 Mar 1;86(3):220-227
pubmed: 32223801
Eur Spine J. 2020 Dec;29(12):3237-3244
pubmed: 32424636
Chin Med J (Engl). 2014;127(23):4092-6
pubmed: 25430455
Neurosurgery. 1993 Jan;32(1):1-8
pubmed: 8421537
Cancer Sci. 2021 Jun;112(6):2416-2425
pubmed: 33780597
Thyroid. 2014 Oct;24(10):1443-55
pubmed: 24827757
Asian Spine J. 2016 Jun;10(3):522-7
pubmed: 27340533
Clin Neurol Neurosurg. 2020 Apr;191:105645
pubmed: 32028128
Thyroid. 2014 Oct;24(10):1488-500
pubmed: 24921429
Spine (Phila Pa 1976). 1997 May 1;22(9):1036-44
pubmed: 9152458
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):499-507
pubmed: 30003994
Ann Surg Oncol. 2014 Apr;21(4):1330-6
pubmed: 24150193
Ann Oncol. 2019 May;30(5):863-870
pubmed: 31987360
BJU Int. 2011 Sep;108(5):673-8
pubmed: 21156017
Spine (Phila Pa 1976). 2005 Oct 1;30(19):2186-91
pubmed: 16205345
Ann Surg Oncol. 2020 Apr;27(4):1180-1188
pubmed: 31848819
Neurosurgery. 2009 Dec;65(6 Suppl):173-81; discussion 181
pubmed: 19934992
Eur Urol. 2007 Jul;52(1):163-8
pubmed: 17098353
Neurosurg Clin N Am. 2020 Apr;31(2):191-200
pubmed: 32147010
World Neurosurg. 2020 May;137:e144-e151
pubmed: 31982597
J Neurosurg Spine. 2014 Nov;21(5):711-8
pubmed: 25170656
Neuro Oncol. 2013 Oct;15(10):1413-9
pubmed: 24057886
Onkologie. 1989 Apr;12(2):92-6
pubmed: 2660050
J Cardiovasc Surg (Torino). 2006 Oct;47(5):603-8
pubmed: 17033612
Clin Neurol Neurosurg. 2014 Jul;122:80-6
pubmed: 24908223
Orthop Clin North Am. 2009 Jan;40(1):47-63, vi
pubmed: 19064055
World Neurosurg. 2019 Feb;122:e1305-e1311
pubmed: 30448587
Ann Surg Oncol. 2014 Dec;21(13):4081-9
pubmed: 25223925
J Neurosurg Spine. 2019 Mar 1;30(3):299-307
pubmed: 30835704
J Neurosurg Spine. 2005 Oct;3(4):288-95
pubmed: 16266070
J Urol. 2020 Feb;203(2):275-282
pubmed: 31393812
Radiother Oncol. 2019 Dec;141:62-66
pubmed: 31526672
J Bone Joint Surg Am. 2017 Sep 6;99(17):1476-1484
pubmed: 28872530
Eur Spine J. 2008 Nov;17(11):1488-95
pubmed: 18787846
J Clin Neurosci. 2019 Oct;68:218-223
pubmed: 31331749
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Clin Neurol Neurosurg. 2018 Jul;170:20-26
pubmed: 29715577
Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1187-92
pubmed: 20959771
Clin Oncol (R Coll Radiol). 2020 Jul;32(7):433-441
pubmed: 32169302
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1016-1026
pubmed: 26025777
World Neurosurg. 2017 Feb;98:217-229
pubmed: 27794510
Spine (Phila Pa 1976). 1992 Oct;17(10):1148-53
pubmed: 1279815
Eur Urol. 2015 May;67(5):913-24
pubmed: 25616710
Spine (Phila Pa 1976). 2019 Aug 15;44(16):1129-1136
pubmed: 30882760
N Engl J Med. 1992 Aug 27;327(9):614-9
pubmed: 1296600
Oncologist. 2013 Jun;18(6):744-51
pubmed: 23709750
J Bone Joint Surg Am. 2016 Nov 2;98(21):1767-1776
pubmed: 27807108
N Engl J Med. 2002 Apr 11;346(15):1128-37
pubmed: 11948273
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806472
pubmed: 30355246
Oncologist. 1999;4(6):459-69
pubmed: 10631690
Ann Thorac Cardiovasc Surg. 2019 Jun 20;25(3):129-141
pubmed: 30971647
Ann Surg Oncol. 2021 May;28(5):2474-2482
pubmed: 33393052
Cancer. 2005 Jan 15;103(2):320-8
pubmed: 15593360
Radiat Oncol. 2014 Oct 16;9:226
pubmed: 25319530
Spine J. 2017 May;17(5):689-708
pubmed: 27988342
Eur Urol. 2013 Apr;63(4):646-52
pubmed: 23041360
Int Orthop. 1994 Oct;18(5):291-8
pubmed: 7852009
Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306
pubmed: 11224867
J Neurosurg Spine. 2010 Oct;13(4):414-7
pubmed: 20887137

Auteurs

Satoshi Kato (S)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Satoru Demura (S)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Kazuya Shinmura (K)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Noriaki Yokogawa (N)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Takaki Shimizu (T)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Hideki Murakami (H)

Department of Orthopaedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Norio Kawahara (N)

Department of Orthopaedic Surgery, Kanazawa Medical University, Kahoku-gun, Japan.

Katsuro Tomita (K)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Hiroyuki Tsuchiya (H)

Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH